These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 38555661

  • 1. Bone quality in zebrafish vertebrae improves after alendronate administration in a glucocorticoid-induced osteoporosis model.
    Bohns FR, Akhtar R, Chuang YJ, Chen PY.
    J Mech Behav Biomed Mater; 2024 Jun; 154():106521. PubMed ID: 38555661
    [Abstract] [Full Text] [Related]

  • 2. Alendronate rescued osteoporotic phenotype in a model of glucocorticoid-induced osteoporosis in adult zebrafish scale.
    Pasqualetti S, Congiu T, Banfi G, Mariotti M.
    Int J Exp Pathol; 2015 Feb; 96(1):11-20. PubMed ID: 25603732
    [Abstract] [Full Text] [Related]

  • 3. The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial.
    Iseri K, Iyoda M, Watanabe M, Matsumoto K, Sanada D, Inoue T, Tachibana S, Shibata T.
    PLoS One; 2018 Feb; 13(3):e0193846. PubMed ID: 29543887
    [Abstract] [Full Text] [Related]

  • 4. Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine.
    Ren H, Shen G, Tang J, Qiu T, Zhang Z, Zhao W, Yu X, Huang J, Liang D, Yao Z, Yang Z, Jiang X.
    Sci Rep; 2017 Sep 06; 7(1):10617. PubMed ID: 28878388
    [Abstract] [Full Text] [Related]

  • 5. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
    Luo Y, Zhang L, Wang WY, Hu QF, Song HP, Su YL, Zhang YZ.
    Bone; 2013 Aug 06; 55(2):439-48. PubMed ID: 23500174
    [Abstract] [Full Text] [Related]

  • 6. Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study.
    Emkey R, Delmas PD, Goemaere S, Liberman UA, Poubelle PE, Daifotis AG, Verbruggen N, Lombardi A, Czachur M.
    Arthritis Rheum; 2003 Apr 06; 48(4):1102-8. PubMed ID: 12687554
    [Abstract] [Full Text] [Related]

  • 7. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L.
    Menopause; 2013 Jan 06; 20(1):72-8. PubMed ID: 22968256
    [Abstract] [Full Text] [Related]

  • 8. Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.
    Allen MR, Burr DB.
    J Bone Miner Res; 2007 Nov 06; 22(11):1759-65. PubMed ID: 17663638
    [Abstract] [Full Text] [Related]

  • 9. Influence of Prednisolone and Alendronate on the de novo Mineralization of Zebrafish Caudal Fin.
    Bohns FR, Shih YR, Chuang YJ, Akhtar R, Chen PY.
    JBMR Plus; 2021 Feb 06; 5(2):e10435. PubMed ID: 33615104
    [Abstract] [Full Text] [Related]

  • 10. Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension.
    Zhang ZL, Liao EY, Xia WB, Lin H, Cheng Q, Wang L, Hao YQ, Chen DC, Tang H, De Peng Y, You L, He L, Hu ZH, Song CL, Wei F, Wang J, Zhang L, Santora AC.
    Osteoporos Int; 2015 Sep 06; 26(9):2365-74. PubMed ID: 25929192
    [Abstract] [Full Text] [Related]

  • 11. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
    Spadaro JA, Damron TA, Horton JA, Margulies BS, Murray GM, Clemente DA, Strauss JA.
    J Orthop Res; 2006 May 06; 24(5):936-44. PubMed ID: 16609966
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide.
    Saag KG, Agnusdei D, Hans D, Kohlmeier LA, Krohn KD, Leib ES, MacLaughlin EJ, Alam J, Simonelli C, Taylor KA, Marcus R.
    Arthritis Rheumatol; 2016 Sep 06; 68(9):2122-8. PubMed ID: 27111239
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.
    Sakai A, Ito M, Tomomitsu T, Tsurukami H, Ikeda S, Fukuda F, Mizunuma H, Inoue T, Saito H, Nakamura T, e-ADVANCED Study Group.
    Osteoporos Int; 2015 Mar 06; 26(3):1193-202. PubMed ID: 25592133
    [Abstract] [Full Text] [Related]

  • 16. Quantitative computed tomographic assessment of bone mineral density changes associated with administration of prednisolone or prednisolone and alendronate sodium in dogs.
    Park S, Oh J, Son KY, Cho KO, Choi J.
    Am J Vet Res; 2015 Jan 06; 76(1):28-34. PubMed ID: 25535658
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N, Giezek H, West J, Schnitzer TJ.
    J Rheumatol; 2009 Aug 06; 36(8):1705-14. PubMed ID: 19487264
    [Abstract] [Full Text] [Related]

  • 19. Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis.
    Johnell O, Scheele WH, Lu Y, Reginster JY, Need AG, Seeman E.
    J Clin Endocrinol Metab; 2002 Mar 06; 87(3):985-92. PubMed ID: 11889149
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.